Pharmacist interventions on antibiotic prescriptions in outpatient pediatric unit in a teaching hospital of Côte d'Ivoire

Annales pharmaceutiques françaises
D P AbrogouaE Doffou

Abstract

The objectives of our study were to analyse the prescriptions of antibiotics and assessing the relevance of pharmacist interventions (PI) in outpatient consultations in a pediatric unit of a Teaching Hospital of Abidjan, Côte d'Ivoire. We conducted a cross-sectional descriptive study from May to December 2013. The analysis of antibiotic prescriptions was documented. The tool of PI classification validated by the French Society of Clinical Pharmacy was used. The PI rating was made by prescribers. This rating evolved from PI0 to PI3 depending on the severity of the clinical impact of the problem and to the severity of clinical consequences avoided by the PI. The relevance was evaluated by the PI acceptance rate by physicians and clinical evaluation of their impact. Our study included 150 patients with a mean age of 11.75 months and a sex ratio (M/F) of 2. The amoxicillin-clavulanic acid (27.2 %) and amoxicillin (22.3 %) were the most prescribed antibiotics. Sixty-three drug-related problems (DRPs) were detected on the antibiotic prescriptions. They were non-optimal drug administration plan (88.9 %) and underdose (11.1 %). The amoxicillin-clavulanic acid (61.9 %) and josamycin (17.4 %) were the most affected by these DRPs. PI were...Continue Reading

References

Jan 8, 1983·British Medical Journal·P J SwindellC E Spence
Oct 28, 1999·Health Policy and Planning·A le GrandF M Haaijer-Ruskamp
Mar 10, 2001·Health Policy and Planning·R LaingD Ross-Degnan
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Philipp M LepperMatthias Trautmann
Jan 30, 2007·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·S Prot-LabartheF Brion
Nov 26, 2008·BMJ : British Medical Journal·Miriam C J M SturkenboomUNKNOWN TEDDY European Network of Excellence
Feb 20, 2009·Malaria Journal·Christopher J M WhittySarah G Staedke
Jul 3, 2009·Médecine et maladies infectieuses·H FaureL Piroth
Nov 10, 2009·BMC Pediatrics·Maria Luisa MoroUNKNOWN "Progetto Bambini a Antibiotici [ProBA]" Regional Group
May 5, 2012·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·N CassirJ-C Lagier
Jun 14, 2012·Acta Paediatrica·Jose StamUNKNOWN Multicenter Infection Prevention Study 1 (MIPS 1) Study Group
May 27, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·A SyllaM-G Sall
Jul 7, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·F DubosA Martinot
Jan 7, 2015·Annales pharmaceutiques françaises·M ChappuyI Carpentier
Apr 30, 2015·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·A SellamC Lévy

❮ Previous
Next ❯

Citations

Sep 4, 2021·Integrated Pharmacy Research & Practice·Elisée DoffouDanho Pascal Abrogoua

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
A D GrantA E Greenberg
© 2022 Meta ULC. All rights reserved